Morral Antoni, Urrutia Gerard, Bonfill Xavier
Facultat de Ciències de la Salut Blanquerna, Universitat Ramon Llull, Barcelona, España.
Centro Cochrane Iberoamericano, Institut d'Investigació Biomèdica, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, España.
Med Clin (Barc). 2017 Jul 7;149(1):26-31. doi: 10.1016/j.medcli.2017.03.034. Epub 2017 May 15.
When we apply a physical or pharmacological treatment, there are many things that may explain the clinical improvement experienced by a patient. The drugs or physical agents applied are important, but we must also add other elements in the context of the patient-therapist relationship. Scientific evidence has proven that the placebo effect exists. This is a true biopsychosocial phenomenon produced by the context in which an intervention is carried out. Biases aside, placebo and nocebo responses are changes in patients' symptoms, due to their participation at the therapeutic meeting, with its rituals, symbols and interactions. This multitude of signals inherent in any intervention, is perceived and interpreted by patients and can create positive or negative expectations.
当我们应用物理或药物治疗时,有许多因素可以解释患者所经历的临床改善情况。所应用的药物或物理手段固然重要,但我们还必须考虑患者与治疗师关系背景中的其他因素。科学证据已证明安慰剂效应的存在。这是一种由干预实施背景所产生的真实的生物心理社会现象。抛开偏差不谈,安慰剂和反安慰剂反应是患者症状的变化,这是由于他们参与治疗过程,包括其中的仪式、象征和互动。任何干预中固有的这些众多信号,会被患者感知和解读,并可能产生积极或消极的期望。